Executive Director, Health Economics & Outcomes Research

The Executive Director, Health Economics & Outcomes Research (HEOR) will proactively help design and actively implement the integrated HEOR strategies and tactics to support the clinical development and commercialization of barzolvolimab and future pipeline assets. The incumbent is expected to have expertise, knowledge, and skills to design and execute a range of studies, health economics models and other HEOR activities including but not limited to comparative effectiveness studies, observational studies using real world data, patient reported outcomes (PROs), and economic/cost-effectiveness modeling for in-line and development compounds as required.